Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

GLP-1

  1. Home>
  2. News>
  3. GLP-1>
  4. Page 2

WHO Adds GLP-1 Drugs and New Cancer Treatments to Essential Medicines List in 2025 Update

  • Post published:May 18, 2026
  • Post category:Knowledge

The World Health Organization (WHO) has updated its Essential Medicines List (EML) in September 2025, adding several landmark drugs including GLP-1 receptor agonists for diabetes and obesity, new cancer treatments,…

Continue Reading WHO Adds GLP-1 Drugs and New Cancer Treatments to Essential Medicines List in 2025 Update
  • Go to the previous page
  • 1
  • 2

Recent Posts

  • India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%
    July 14, 2026/
    0 Comments
  • Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide
    July 5, 2026/
    0 Comments
  • Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026
    July 4, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India Pharma July 2026: CETA Effect, FDA Filings Lead, Market Grows 16%
  • Understanding WHO Prequalification for Indian Generic Medicines: A Buyer’s Guide
  • Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026
  • India’s Generic Drug Quality Revolution: Schedule M and CDSCO Audit Guide 2026
  • India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve